Rare diseases
Investigational molecules
Locations
Back to Poland6 clinical trials in Dabrowka, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
PolandA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
PolandA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
PolandStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
PolandStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on psoriatic arthritis treatments, specifically designed for patients who haven't previously received biologic medications.
These studies aim to evaluate innovative treatment options including zasocitinib and sonelokimab for improving patient outcomes.
Research centered on understanding and treating active psoriatic arthritis through various therapeutic mechanisms and treatment modalities.
Current trials are exploring the efficacy of deucravacitinib and other targeted therapies in managing autoimmune manifestations.
Innovative research comparing biological treatment alternatives against placebo to establish new standards in arthritis care.
These studies focus on developing safe and effective treatments for patients with active joint disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
